Literature DB >> 2988731

Clonidine in spinal cord injury.

P W Nance, A H Shears, D M Nance.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988731      PMCID: PMC1346067     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Functional restoration of the traumatically injured spinal cord in cats by clonidine.

Authors:  N E Naftchi
Journal:  Science       Date:  1982-09-10       Impact factor: 47.728

Review 2.  Distribution of alpha 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents.

Authors:  J R Unnerstall; T A Kopajtic; M J Kuhar
Journal:  Brain Res       Date:  1984-03       Impact factor: 3.252

3.  Clonidine, a centrally acting sympathetic inhibitor, as monotherapy for mild to moderate hypertension.

Authors:  C Thananopavarn; M S Golub; P Eggena; J D Barrett; M P Sambhi
Journal:  Am J Cardiol       Date:  1982-01       Impact factor: 2.778

  3 in total
  6 in total

Review 1.  Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury.

Authors:  Alexander G Rabchevsky; Patrick H Kitzman
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

2.  A Review of Spasticity Treatments: Pharmacological and Interventional Approaches.

Authors:  Eric Chang; Nilasha Ghosh; Daniel Yanni; Sujin Lee; Daniela Alexandru; Tahseen Mozaffar
Journal:  Crit Rev Phys Rehabil Med       Date:  2013

3.  Antispastic effects of L-dopa.

Authors:  J Eriksson; B Olausson; E Jankowska
Journal:  Exp Brain Res       Date:  1996-09       Impact factor: 1.972

4.  Regulation of soleus muscle spindle sensitivity in decerebrate and spinal cats during postural and locomotor activities.

Authors:  D J Bennett; S J De Serres; R B Stein
Journal:  J Physiol       Date:  1996-09-15       Impact factor: 5.182

5.  Clonidine in the treatment of spasticity in patients with multiple sclerosis.

Authors:  O A Khan; M J Olek
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

6.  Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment.

Authors:  Herbert R Henney; Michael Chez
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.